Lamis Yehia

1.5k total citations
48 papers, 883 citations indexed

About

Lamis Yehia is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Lamis Yehia has authored 48 papers receiving a total of 883 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Lamis Yehia's work include PI3K/AKT/mTOR signaling in cancer (29 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (6 papers). Lamis Yehia is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (29 papers), Cancer Genomics and Diagnostics (6 papers) and Genetic factors in colorectal cancer (6 papers). Lamis Yehia collaborates with scholars based in United States, Lebanon and Singapore. Lamis Yehia's co-authors include Charis Eng, Joanne Ngeow, Ying Ni, Farshad Niazi, Roshan Padmanabhan, Brandie Heald, Marwan El‐Sabban, Sara Akhavanfard, Ziyad Mahfoud and Mark N. Jabbour and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Lamis Yehia

44 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lamis Yehia United States 17 543 164 152 148 104 48 883
Nicolas Gadot France 20 520 1.0× 197 1.2× 108 0.7× 87 0.6× 56 0.5× 46 990
Ana M. Jiménez‐Lara Spain 16 441 0.8× 114 0.7× 91 0.6× 204 1.4× 139 1.3× 21 719
Tzipora C. Falik‐Zaccai Israel 19 326 0.6× 116 0.7× 75 0.5× 191 1.3× 63 0.6× 56 809
Allison C. Sharrow United States 12 559 1.0× 238 1.5× 110 0.7× 208 1.4× 56 0.5× 16 1.0k
Yao‐Shan Fan United States 18 346 0.6× 171 1.0× 77 0.5× 432 2.9× 72 0.7× 39 913
Dillon Phan United States 12 792 1.5× 158 1.0× 143 0.9× 160 1.1× 39 0.4× 16 1.0k
Karl Worm Germany 22 602 1.1× 305 1.9× 421 2.8× 89 0.6× 115 1.1× 53 1.3k
Takahide Tohmonda Japan 20 598 1.1× 142 0.9× 90 0.6× 137 0.9× 28 0.3× 24 905
Mikhail N. Zoubine United States 13 309 0.6× 88 0.5× 84 0.6× 64 0.4× 186 1.8× 17 705

Countries citing papers authored by Lamis Yehia

Since Specialization
Citations

This map shows the geographic impact of Lamis Yehia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamis Yehia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamis Yehia more than expected).

Fields of papers citing papers by Lamis Yehia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lamis Yehia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamis Yehia. The network helps show where Lamis Yehia may publish in the future.

Co-authorship network of co-authors of Lamis Yehia

This figure shows the co-authorship network connecting the top 25 collaborators of Lamis Yehia. A scholar is included among the top collaborators of Lamis Yehia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lamis Yehia. Lamis Yehia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhawan, Andrew, Lamis Yehia, Marc Tischkowitz, et al.. (2025). Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumor Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group. Clinical Cancer Research. 31(9). 1754–1765. 1 indexed citations
2.
Li, Lin, et al.. (2025). Metabolic signatures of immune checkpoint inhibitor response in gynecologic cancers: Insights from flux balance analysis. Computers in Biology and Medicine. 200. 111366–111366.
3.
Yehia, Lamis, et al.. (2025). Extended spectrum of cancers in PTEN hamartoma tumor syndrome. npj Precision Oncology. 9(1). 61–61.
4.
5.
Yehia, Lamis, Carol A. Burke, Steven C. Campbell, et al.. (2023). Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants. JAMA Network Open. 6(4). e239705–e239705. 20 indexed citations
6.
Yehia, Lamis, et al.. (2023). The mitochondrial genome as a modifier of autism versus cancer phenotypes in PTEN hamartoma tumor syndrome. Human Genetics and Genomics Advances. 4(3). 100199–100199. 2 indexed citations
7.
Yehia, Lamis, Jin Jiang, Carole Macaron, et al.. (2023). Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. Yearbook of pediatric endocrinology. 8 indexed citations
8.
Yehia, Lamis & Charis Eng. (2023). Genetics and genomics in healthcare: the future is now. Singapore Medical Journal. 64(1). 4–6. 1 indexed citations
9.
Yehia, Lamis, Brandie Heald, & Charis Eng. (2023). Clinical Spectrum and Science Behind the Hamartomatous Polyposis Syndromes. Gastroenterology. 164(5). 800–811. 10 indexed citations
10.
Brewer, Takae, Lamis Yehia, Peter Bazeley, & Charis Eng. (2022). Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants. The American Journal of Human Genetics. 109(8). 1520–1533. 4 indexed citations
11.
Morgan, Frederick, Lamis Yehia, Christine M. McDonald, et al.. (2022). Characterizing dermatologic findings among patients with PTEN hamartoma tumor syndrome: Results of a multicenter cohort study. Journal of the American Academy of Dermatology. 89(1). 90–98. 4 indexed citations
12.
Brewer, Takae, et al.. (2022). Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations. Thyroid. 32(9). 1094–1100. 11 indexed citations
13.
Yehia, Lamis, et al.. (2021). Non-canonical role of wild-type SEC23B in the cellular stress response pathway. Cell Death and Disease. 12(4). 304–304. 3 indexed citations
14.
Busch, Robyn M., Lamis Yehia, Peter Bazeley, et al.. (2020). Verbal memory dysfunction is associated with alterations in brain transcriptome in dominant temporal lobe epilepsy. Epilepsia. 61(10). 2203–2213. 7 indexed citations
15.
Saghir, Jamal El, Abdullah Shaito, Sara Al‐Ghadban, et al.. (2019). Cx43 Expression Correlates with Breast Cancer Metastasis in MDA-MB-231 Cells In Vitro, In a Mouse Xenograft Model and in Human Breast Cancer Tissues. Cancers. 11(4). 460–460. 38 indexed citations
16.
Yehia, Lamis & Charis Eng. (2018). 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine. Endocrine Related Cancer. 25(8). T121–T140. 43 indexed citations
17.
Jehi, Lara, Lamis Yehia, Charissa Peterson, et al.. (2018). Preliminary report: Late seizure recurrence years after epilepsy surgery may be associated with alterations in brain tissue transcriptome. Epilepsia Open. 3(2). 299–304. 14 indexed citations
18.
Ni, Ying, Benjamin Fletcher, Todd Romigh, et al.. (2016). Germline compound heterozygous poly-glutamine deletion inUSF3may be involved in predisposition to heritable and sporadic epithelial thyroid carcinoma. Human Molecular Genetics. 26(2). ddw382–ddw382. 13 indexed citations
19.
Yehia, Lamis, Farshad Niazi, Ying Ni, et al.. (2015). Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. The American Journal of Human Genetics. 97(5). 661–676. 52 indexed citations
20.
Yehia, Lamis, Wasim F. Raslan, Abdul‐Ghani Kibbi, et al.. (2012). Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. Journal of Cutaneous Pathology. 39(3). 347–355. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas Gadot Breakdown of academic impact, for papers by Ana M. Jiménez‐Lara Breakdown of academic impact, for papers by Tzipora C. Falik‐Zaccai Breakdown of academic impact, for papers by Allison C. Sharrow Breakdown of academic impact, for papers by Yao‐Shan Fan Breakdown of academic impact, for papers by Dillon Phan Breakdown of academic impact, for papers by Karl Worm Breakdown of academic impact, for papers by Takahide Tohmonda Breakdown of academic impact, for papers by Mikhail N. Zoubine
Rankless by CCL
2026